Humalog and NovoLog are not the same insulin, but they are remarkably similar. Both are rapid-acting insulin analogs with nearly identical onset times (10 to 15 minutes), peak windows (1 to 3 hours), and durations (3 to 5 hours). The key difference is the active ingredient: Humalog contains insulin lispro, while NovoLog contains insulin aspart. These are two distinct molecules, both lab-modified versions of human insulin, made by different manufacturers.
Different Molecules, Same Category
Humalog, made by Eli Lilly, uses insulin lispro. NovoLog, made by Novo Nordisk, uses insulin aspart. Both were created by slightly altering the amino acid structure of natural human insulin so it absorbs faster after injection. The modifications are different for each product, which is why they have separate brand names and separate FDA approvals, but the end result is functionally very close.
Because they contain different active ingredients, the FDA does not consider Humalog and NovoLog interchangeable. A pharmacist cannot swap one for the other without a new prescription from your doctor. They are not biosimilars of each other either. A biosimilar is a near-copy of one specific reference product, and no rapid-acting insulin biosimilar has been granted full interchangeability status by the FDA. If your insurance plan covers one but not the other, you’ll need your prescriber to write for the covered product specifically.
How They Perform Side by Side
In practical terms, Humalog and NovoLog behave almost identically. Both start lowering blood sugar within 10 to 15 minutes of injection. Both hit their strongest effect somewhere between 1 and 3 hours later. And both wear off within 3 to 5 hours. For most people with diabetes, this means either insulin covers a meal in roughly the same way: you inject shortly before eating, the insulin peaks while your food is being digested, and it tapers off before your next meal.
Individual response can vary slightly. Some people find one works a few minutes faster or lasts a bit longer than the other for them personally. These differences tend to be small, and many people who’ve used both report no noticeable difference at all. If your doctor switches you from one to the other, you may be asked to monitor your blood sugar more closely for a few days to confirm the new insulin is covering your meals the same way.
Available Forms and Concentrations
One area where the two brands genuinely differ is in their product lineups. Humalog is available in two concentrations: the standard U-100 (100 units per milliliter) and a more concentrated U-200 (200 units per milliliter). The U-200 option comes only in prefilled pens and is designed for people who need larger doses, since it delivers the same number of units in half the liquid volume. NovoLog is available only in U-100 concentration.
Humalog’s U-100 comes in several delivery formats: standard vials, prefilled KwikPens, Tempo Pens, Junior KwikPens (which dose in half-unit increments for children or adults needing fine adjustments), and cartridges for reusable pens. NovoLog similarly offers vials, prefilled FlexPens, and cartridges for its Penfill system. Both insulins can be used in insulin pumps for continuous subcutaneous delivery. Humalog’s label specifically mentions compatibility with pumps from major manufacturers, though you should always verify that your specific pump model is approved for whichever insulin you use.
Storage Works the Same Way
Unopened vials and pens of both Humalog and NovoLog should be stored in the refrigerator. Once you open a vial or start using a pen, both insulins stay effective at room temperature (between 59°F and 86°F) for up to 28 days. After that, potency drops and the insulin should be discarded. This 28-day window is the same for both products, so switching from one to the other doesn’t change your storage routine.
Cost and Insurance Coverage
The most meaningful difference between Humalog and NovoLog for many people comes down to cost. Both are brand-name insulins with similar list prices, but insurance formularies often prefer one over the other. Your copay for Humalog could be significantly higher or lower than for NovoLog depending on your plan. If you’re paying out of pocket, it’s worth checking whether either brand offers savings programs or whether a follow-on product (like Admelog, a lower-cost alternative to Humalog that uses the same insulin lispro molecule) might be available to you.
Can You Switch Between Them?
Switching from Humalog to NovoLog, or vice versa, is common and generally straightforward. Because their timing profiles match so closely, most people transition at the same dose without needing major adjustments. Your doctor will typically keep your doses the same and ask you to check your blood sugar a bit more frequently during the first week or so to make sure everything is tracking as expected.
The most common reason for switching is a change in insurance coverage, but some people switch because one pen design feels more comfortable, because they need the U-200 concentration only Humalog offers, or simply because of a supply issue. Whatever the reason, the transition is one of the simpler medication changes in diabetes management.